CTRV Insider Trading Activity and SEC Form 4 Filings
CTRV insider trading summary
No open-market insider purchases or sales of ContraVir Pharmaceuticals, Inc. (CTRV) have been reported on SEC Form 4 in the past 12 months.
Latest CTRV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 20, 2017 | John T Cavan | CFO | Buy | $13K (20,000 @ $0.65) |
| Feb 18, 2016 | James Sapirstein | Chief Executive Officer | Buy | $10K (10,000 @ $1.00) |
| Nov 30, 2015 | James Sapirstein | Chief Executive Officer | Buy | $1K (500 @ $2.15) |
| Nov 23, 2015 | James Sapirstein | Chief Executive Officer | Buy | $4K (2,500 @ $1.64) |
| Mar 4, 2014 | John P Brancaccio | Director | Buy | $7K (4,393 @ $1.49) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.